MAX
scPharmaceuticals Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-2.5 | 29.98 | -108.34% | -4.25 | -41.13% |
| P/S |
|
4.29 | 127.74 | -96.64% |
|
|
| P/BV |
|
11.7 | 249.13 | -95.3% |
|
|
| P/FCF |
|
-3.02 | -171.72 | -98.24% |
|
|
| Ev/Ebitda |
|
-1.72 | -23.82 | -92.8% |
|
|
| Ev/S |
|
3.66 | 524.37 | -99.3% |
|
|
| Ev/FCF |
|
-1.88 | -276.27 | -99.32% |
|
|
| E/P |
|
-0.4 | 0.0223 | -1892.14% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-213.12 | -358.56 | -40.56% | -516.22 | -58.72% |
| ROE |
|
-336.97 | 102.4 | -429.07% |
|
|
| ROA |
|
-84.31 | -1.94 | 4240.94% |
|
|
| ROIC |
|
0 | 0.7 | -100% |
|
|
| ROS |
|
-178.29 | -148.28 | 20.24% |
|
|
| ROCE |
|
-582.42 | 3.78 | -15523.9% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.68 | 1.52 | -144.82% | -0.81 | -15.9% |
| Nеt Debt/Ebitda |
|
0.3 | 1.46 | -79.69% |
|
|
| Debt/Ratio |
|
0.49 | 0.2 | 147.8% |
|
|
| Debt/Equity |
|
7.07 | 1.61 | 340.05% |
|
|
| Debt/Net Income |
|
-0.62 | -1.12 | -44.92% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.55 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.91 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 3.92 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.51 | -100% |
|
|
| Average percentage for payments |
|
0 | 56.13 | -100% |
|
|
| Difference from average difference in sector |
|
-0.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
1661.12 | -47.77 | -3577.33% | ||
| Growth impulse Ebitda in 5 years |
|
162.17 | -76.11 | -313.07% | ||
| Growth impulse Net Income in 5 years |
|
164.36 | -71.25 | -330.68% | ||
| Growth impulse FCF in 5 years |
|
154.73 | -63.52 | -343.59% | ||
| Growth impulse EPS in 5 years |
|
48.26 | -37.1 | -230.08% |
IP Score
4.32/10
